STSA-1002 Injection

STSA-1002 · Staidson (Beijing) Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STSA-1002 Injection, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome [Phase 1, Phase 2]

See pricing